National_Coverage_Determinations_Manual / New_Topic7

Why This Topic Matters

Coverage determinations can affect whether a therapy is considered reasonable and necessary for Medicare payment in a specific clinical setting. Understanding the scope of this policy helps billing, coding, and reimbursement staff recognize when the article applies to oncology-related treatment claims.

Article Sections

1. General

   Provides background on chemotherapy-induced nausea and vomiting, common contributing factors, and the general clinical context for anti-emetic management.

2. Nationally Covered Indications

   Summarizes the Medicare coverage determination, the effective date, and the covered patient population and treatment setting addressed by the policy.

3. Nationally Noncovered Indications

   States the setting in which the therapy is not covered under this determination.

4. Other

   Contains a brief administrative note and review date information.